Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives

Volume: 100, Pages: 102288 - 102288
Published: Nov 1, 2021
Abstract
Multiple systemic treatments are currently available for advanced cancers of the digestive tract, but none of them is curative. Adoptive T-cell immunotherapy refers to the extraction, modification and re-infusion of autologous or allogenic T lymphocytes for therapeutic purposes. A number of clinical trials have investigated either non-engineered T cells (i.e., lymphokine-activated killer cells, cytokine induced killer cells, or...
Paper Details
Title
Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives
Published Date
Nov 1, 2021
Volume
100
Pages
102288 - 102288
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.